XML 46 R9.htm IDEA: XBRL DOCUMENT v3.20.1
Acquisitions and Disposals
3 Months Ended
Mar. 31, 2020
Business Combinations [Abstract]  
Acquisitions and Disposals
Acquisitions and Disposals
Acquisitions
During the three months ended March 31, 2020, the Company acquired a controlling interest in a surgical facility in a new market and a surgical facility in an existing market that was merged into an existing facility for total cash consideration of $5.5 million, net of cash acquired. The cash consideration was funded through cash from operations. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):
Total consideration
 
$
6.1

Fair value of non-controlling interests
 
3.5

Aggregate acquisition date fair value
 
$
9.6

Net assets acquired:
 
 
Current assets
 
$
1.5

Property and equipment
 
1.1

Goodwill
 
8.3

Right-of-use operating lease assets
 
5.4

Current liabilities
 
(1.3
)
Right-of-use operating lease liabilities
 
(5.4
)
Aggregate acquisition date fair value
 
$
9.6


The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the three months ended March 31, 2020, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2019. The goodwill acquired was allocated to the Company's surgical facility services reportable segment. The results of operations of the acquisitions were included in the Company’s results of operations beginning on the dates of acquisition and were not considered significant for the three months ended March 31, 2020.
Disposals
During the three months ended March 31, 2020, the Company sold its interests in two surgery centers, one of which was previously accounted for as an equity method investment, for net cash proceeds of $9.4 million, and recognized a net pre-tax loss of $3.1 million included in loss on disposals and deconsolidations, net in the condensed consolidated statement of operations for the three months ended March 31, 2020.